Improving lung cancer screening for African Americans
A Multilevel intervention to address health disparities in lung cancer screening
This study is working to help more African Americans get screened for lung cancer by improving awareness and communication between doctors and patients, so everyone understands how important early detection is for better health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11046526 on NIH RePORTER |
What this research studies
This research aims to enhance lung cancer screening rates among African Americans, who face significant disparities in access and awareness. It will implement a multilevel intervention targeting both healthcare providers and patients to address barriers to screening. The study will focus on increasing knowledge about lung cancer and the importance of early detection, as well as improving communication between providers and patients. By addressing these issues, the research seeks to increase the utilization of recommended lung screenings.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals who are at high risk for lung cancer and may benefit from increased screening.
Not a fit: Patients who are not at high risk for lung cancer or who do not belong to the African American population may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased lung cancer screening rates and improved early detection among African Americans, ultimately reducing mortality from lung cancer.
How similar studies have performed: Previous research has shown that multilevel interventions can effectively address health disparities in cancer screening, indicating a promising approach for this study.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Williams, Randi M. — Georgetown University
- Study coordinator: Williams, Randi M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.